SYSBIOTECH SARL took part in the WCBVF 2016

“World-China Biosimilars & Novel Vaccines Forum” was carried out in Shanghai on March 16-17, 2016 in the form of international annual conference. This is the only platform in China that provides capability of technical exchange and strategic collaboration for Chinese biosimilar and vaccine players, Chinese regulators and global leading biopharmas. WCBVF has two streams- Biosimilars and Novel Vaccines.

WCBVF 2016  was considered the latest Chinese Biosimilars and Vaccines Regulatory Guideline to have in-depth discussion on biosimilarity factors in up-down stream development and clinical trials in Biosimilars Forum.

Up to 800 participants worldwide from the biopharmacy industry has participated and shared their thoughts.